Robinson Pharma Enhances Manufacturing with New High-Speed Production and Expanded Capabilities

Robinson Pharma Inc., a prominent contract manufacturer of dietary supplements based in the USA, has recently made headlines with the announcement of a significant expansion in its manufacturing capabilities. This move comes as a response to the growing demand for quality dietary supplements across both domestic and international markets.

On December 18, 2025, the company unveiled its brand new high-speed liquid production line, which is capable of operating at speeds up to three times faster than the previous systems. This advancement is a testament to Robinson Pharma's commitment to investing in innovative manufacturing technologies to enhance operational efficiency and scalability. The new liquid line is designed not just for speed but also emphasizes the importance of quality and compliance, ensuring that all products meet the high standards expected by consumers and regulatory bodies alike.

Robinson Pharma is no stranger to large-scale production. It is already recognized as the largest softgel manufacturer in the United States. As part of the expansion, the company has introduced additional manufacturing machinery for tablets and capsules, amplifying its production output. Specifically, the number of tablet compression machines has increased from eight to eleven, providing greater flexibility and quicker turnaround times for tablet production. This is a critical improvement for meeting customer demands rapidly and efficiently.

In addition to tablets, the company has also ramped up its capsule manufacturing operations. With new state-of-the-art capsule production lines, Robinson Pharma now has a total of thirteen lines, up from nine previously. This increase in capacity not only helps accommodate the rising demand for various capsule formats but also enhances the company's ability to deliver diverse formulations to its customers.

The softgel production lines have also seen significant upgrades, indicating Robinson Pharma's emphasis on meeting high-demand scenarios. Its facility is capable of producing an incredible 23 billion softgels each year, supported by a robust infrastructure that includes 30 high-throughput softgel machines and 30 continuous drying tunnels. This allows the company to maintain its leading position in the market while ensuring the quality of its products remains uncompromised.

Robinson Pharma's expansion aligns with its goal of becoming an even more reliable partner for businesses seeking comprehensive dietary supplement manufacturing solutions. With capabilities that encompass softgels, liquids, tablets, gummies, and capsules, the company is strategically positioned to adapt to the evolving needs of the health and wellness industry.

As consumer preferences shift and grow, Robinson Pharma is poised to support an expanding array of nutritional products with its enhanced facilities. Companies looking for manufacturing partners in the dietary supplement arena can find a trustworthy ally in Robinson Pharma, which continues to set the standard for quality and service.

For additional information on Robinson Pharma's new manufacturing capabilities or to explore potential partnership opportunities, visit www.robinsonpharma.com or reach out via email at [email protected]. Interested parties can also call their office at 714-241-0235 to discuss their specific supplement manufacturing needs.

Founded in 1989, Robinson Pharma is celebrated for its capacity, competitive pricing, and stringent quality controls in the nutraceutical sector. The company has built a solid reputation, recognized globally for custom formulations and packaging solutions, making it one of the most trusted names in the industry.

Topics Consumer Products & Retail)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.